⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBRX News
ImmunityBio, Inc. Common Stock
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Chairman Allegedly Misled on Drug Efficacy: Levi & Korsinsky
globenewswire.com
IBRX
ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.
globenewswire.com
IBRX
Kessler Topaz Meltzer & Check, LLP - ImmunityBio, Inc. Class Action Lawsuit: Investors Face May 26, 2026, Deadline
globenewswire.com
IBRX
LU UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Lufax (LU) Investors of Securities Class Action Deadline on May 20, 2026 Ready to Announce with Confidence?
newsfilecorp.com
LU
LAKE
IBRX
IBRX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026 Ready to Announce with Confidence?
newsfilecorp.com
IBRX
Portnoy Law Firm Announces Class Action on Behalf of ImmunityBio, Inc. Investors
globenewswire.com
IBRX
INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman
globenewswire.com
IBRX
ImmunityBio, Inc. (IBRX) Investors: May 26, 2026 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
accessnewswire.com
IBRX
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ImmunityBio, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
IBRX
Pomerantz LLP Issues Reminder to Investors in ImmunityBio, Inc. of Class Action Filing – IBRX
accessnewswire.com
IBRX